The Biotech Startups Podcast
🧬 Science Is Twenty Percent of the Problem | James Evans Rerelease (2/3)
November 9, 2026
Paul Matsudaira took a job in Singapore, and James Evans did not wake up one morning craving entrepreneurship. He left MIT's Whitehead Institute, bounced through venture-backed biotechs, and got a baptism of fire defending data in rooms that wanted a fight. One San Diego client won a contract, and that was enough to plant PhenoVista in California with a year of runway and no paying customers yet.
Need new or refurbished lab equipment? Excedr provides research labs with equipment leases on founder-friendly terms to support paths to exceptional outcomes. Learn more at https://www.excedr.com/ and explore our partner network: https://www.excedr.com/partners

β€œThe science does need to be good, but it's probably 10 or 20% of the problem.”

Paul Matsudaira took a job in Singapore, and James Evans did not wake up one morning craving entrepreneurship. He left MIT's Whitehead Institute, bounced through venture-backed biotechs, and got a baptism of fire defending data in rooms that wanted a fight. One San Diego client won a contract, and that was enough to plant PhenoVista in California with a year of runway and no paying customers yet.

The culture shock was the point. Academia does not restructure a lab because a fund's priorities changed. Private-sector science does, and it felt unfair. His wife is the reason the company exists. She believed first, then kept bringing home the HR and ops problems nobody warns you about. If people had told him, he says he wouldn't have listened.

iPS-derived cells were still new, the market had a hole, and they never wrote a business plan. They mapped rent, salaries, and grants on the back of the old-fashioned way, because James had no fundraising network from those earlier VC-backed seats. Bootstrap was necessity, not branding. Getting Erica on payroll was the moment the tissue-culture-in-a-hot-room era had to get slightly more professional.

Key Topics Covered:

If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening.

──────────────────────────────────────────────────
Links:
Subscribe to the Podcast:
Apple: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994
Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4
YouTube: https://www.youtube.com/@thebiotechstartupspodcast
Website: https://www.thebiotechstartupspodcast.com/?utm_source=podcast&utm_medium=show-notes&utm_campaign=the-biotech-startups-podcast-ep292

Find our guest, James Evans, at these links:
LinkedIn: https://www.linkedin.com/in/jamesgevans
Website: https://phenovista.com/

Find our host, Jon Chee, at these links:
LinkedIn: https://www.linkedin.com/in/jonchee/

Learn more about Excedr:
LinkedIn: https://www.linkedin.com/company/excedr/
Website: https://www.excedr.com/

Intro & Outro Songs Created by OkKyojin:
https://flow.page/kyojin

Resources & Articles:
How to Choose the Right Contract Research Organization: https://www.excedr.com/blog/contract-research-organizations
A Guide to Writing a Small Business Grant Proposal: https://www.excedr.com/blog/how-to-write-a-small-business-grant-proposal
How Do Core Labs Support Life Science Research?: https://www.excedr.com/blog/core-labs

Companies, Universities, & People Mentioned:
Whitehead Institute: https://wi.mit.edu/
Massachusetts Institute of Technology: https://www.mit.edu/
National University of Singapore: https://www.nus.edu.sg/

Timestamps:
00:00 Intro
01:19 Paul Moves to Singapore
04:06 Baptism of Fire
04:16 A Client in San Diego
05:27 No Paying Clients and a Year of Runway
07:26 Getting Erica
09:06 Academia Meets Venture Backing
09:31 Restructuring That Felt Unfair
12:42 I Wouldn't Have Started Without My Wife
14:05 You Wouldn't Listen If They Told You
14:15 Science Is Twenty Percent of the Problem
15:45 iPS Cells and a Gap in the Market
17:17 We Never Wrote a Business Plan
18:32 Bootstrap by Necessity
19:53 Outro



The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science companyβ€”from pre-seed to IPO.